April 22, 2020 AACR 2020 preview – no Tigit, but plenty of novel mechanisms Next week’s virtual meeting could resuscitate Ox40 agonists, but an important omission will disappoint.
February 07, 2019 Sanofi does a spring clean The French company has taken a look at its R&D portfolio, and made some radical changes in oncology and diabetes.
